Discovery of immunopotentiatory drugs: current and future strategies.
作者信息
Rhodes J
机构信息
Department of Gene and Protein Therapeutics, Glaxo Smith Kline Research and Development, Medicines Research Centre, Stevenage, UK.
出版信息
Clin Exp Immunol. 2002 Dec;130(3):363-9. doi: 10.1046/j.1365-2249.2002.02016.x.
Abstract
摘要
相似文献
1
Discovery of immunopotentiatory drugs: current and future strategies.
Clin Exp Immunol. 2002 Dec;130(3):363-9. doi: 10.1046/j.1365-2249.2002.02016.x.
2
Imiquimod: modes of action.
Br J Dermatol. 2003 Nov;149 Suppl 66:5-8. doi: 10.1046/j.0366-077x.2003.05628.x.
3
New insights into imiquimod's mechanisms of action.
J Drugs Dermatol. 2004 May-Jun;3(3):247-9.
4
Innate immune trouble detectors.
Trends Immunol. 2001 May;22(5):235-6. doi: 10.1016/s1471-4906(01)01915-9.
5
Enhanced type I interferon signaling and recruitment of chemokine receptor CXCR3-expressing lymphocytes into the skin following treatment with the TLR7-agonist imiquimod.
J Cutan Pathol. 2005 Apr;32(4):257-62. doi: 10.1111/j.0303-6987.2005.00297.x.
6
Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?
Clin Cancer Res. 2004 Aug 1;10(15):4959-70. doi: 10.1158/1078-0432.CCR-04-0193.
7
Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation.
J Exp Med. 2003 Jan 6;197(1):101-9. doi: 10.1084/jem.20021908.
8
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.
Nat Immunol. 2002 Feb;3(2):196-200. doi: 10.1038/ni758. Epub 2002 Jan 22.
9
Unraveling the mechanisms by which heat shock proteins activate the immune system.
Curr Opin Mol Ther. 2001 Feb;3(1):25-30.
10
Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
J Exp Med. 2000 Aug 21;192(4):595-600. doi: 10.1084/jem.192.4.595.
引用本文的文献
1
X-ray crystallography and sickle cell disease drug discovery-a tribute to Donald Abraham.
Front Mol Biosci. 2023 May 24;10:1136970. doi: 10.3389/fmolb.2023.1136970. eCollection 2023.
2
Modulating hemoglobin allostery for treatment of sickle cell disease: current progress and intellectual property.
Expert Opin Ther Pat. 2022 Feb;32(2):115-130. doi: 10.1080/13543776.2022.1994945. Epub 2021 Nov 1.
3
Dendrophthoe pentandra (L.) Miq extract effectively inhibits inflammation, proliferation and induces p53 expression on colitis-associated colon cancer.
BMC Complement Altern Med. 2016 Sep 26;16(1):374. doi: 10.1186/s12906-016-1345-0.
4
Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.
Acc Chem Res. 2016 Sep 20;49(9):1741-56. doi: 10.1021/acs.accounts.6b00242. Epub 2016 Aug 28.
5
Successful treatment of lower eyelid melanoma in situ.
Plast Reconstr Surg Glob Open. 2014 Jun 6;2(5):e154. doi: 10.1097/GOX.0000000000000041. eCollection 2014 May.
6
Design, synthesis, and immunologic evaluation of vaccine adjuvant conjugates based on QS-21 and tucaresol.
Bioorg Med Chem. 2014 Nov 1;22(21):5917-23. doi: 10.1016/j.bmc.2014.09.016. Epub 2014 Sep 17.
7
Immunomodulatory effects of and on mice splenocytes and thymocytes.
Exp Ther Med. 2014 Jun;7(6):1733-1737. doi: 10.3892/etm.2014.1657. Epub 2014 Apr 2.
8
Therapeutic strategies to alter the oxygen affinity of sickle hemoglobin.
Hematol Oncol Clin North Am. 2014 Apr;28(2):217-31. doi: 10.1016/j.hoc.2013.11.001. Epub 2014 Jan 21.
9
Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.
Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10172-7. doi: 10.1073/pnas.0914561107. Epub 2010 May 24.
10
Discovery of novel immunostimulants by dendritic-cell-based functional screening.
Blood. 2005 Nov 1;106(9):3082-9. doi: 10.1182/blood-2005-03-1161. Epub 2005 Jul 7.
本文引用的文献
1
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848.
Nat Immunol. 2002 Jun;3(6):499. doi: 10.1038/ni0602-499.
2
T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.
Nat Immunol. 2002 Jun;3(6):549-57. doi: 10.1038/ni794. Epub 2002 May 13.
3
T-cell antigen receptor signal transduction.
Immunology. 2002 Apr;105(4):369-74. doi: 10.1046/j.1365-2567.2002.01391.x.
4
The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase.
Curr Opin Infect Dis. 2001 Dec;14(6):757-64. doi: 10.1097/00001432-200112000-00015.
5
Decoding the patterns of self and nonself by the innate immune system.
Science. 2002 Apr 12;296(5566):298-300. doi: 10.1126/science.1068883.
6
MAP kinases in the immune response.
Annu Rev Immunol. 2002;20:55-72. doi: 10.1146/annurev.immunol.20.091301.131133. Epub 2001 Oct 4.
7
Toll-like receptors: mammalian "taste receptors" for a smorgasbord of microbial invaders.
Curr Opin Microbiol. 2002 Feb;5(1):70-5. doi: 10.1016/s1369-5274(02)00288-6.
8
Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway.
Nat Immunol. 2002 Feb;3(2):196-200. doi: 10.1038/ni758. Epub 2002 Jan 22.
9
Multiple myeloma: present and future.
Curr Opin Oncol. 2002 Jan;14(1):31-5. doi: 10.1097/00001622-200201000-00006.
10
Regulatory mechanisms for receptor protein tyrosine phosphatases.
Chem Rev. 2001 Aug;101(8):2441-8. doi: 10.1021/cr000085m.
Zotero 插件